Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Histiocytoma, Malignant Fibrous × talimogene laherparepvec × Clear all

Sponsor

Conditions

Melanoma 8 Sarcoma 3 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Inflammatory Breast Neoplasms 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 Advanced Non CNS Tumors 1 Adenocarcinoma 1

Interventions

Doxorubicin 5 pazopanib 3 Ifosfamide 3 pembrolizumab 2 Sunitinib 2 Radiotherapy, Conformal 2 Radiotherapy 2 tremelimumab 1 temsirolimus 1 sintilimab 1 saracatinib 1 romidepsin 1 olaratumab 1 liposomal doxorubicin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Sorafenib 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Nivolumab 1 Neoadjuvant Therapy 1 Methotrexate 1 MLN 8237 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡